Rwanda

previous Print
HIV/AIDS Statistics for Rwanda

Total population in thousands (2007): 9,725*
Number of people living with HIV (2007): 150,000*
Adults aged 15 to 49 prevalence rate (2007): 2.8*
Adults aged 15 and up living with HIV (2007): 130,000*
Women aged 15 and up living with HIV (2007): 78,000*
Children aged 0 to 14 living with HIV (2007): 19,000*
Prevalence among male 15 to 24 year old (2007):  0.5*
Prevalence among female 15 to 24 year old (2007): 1.4*
Deaths due to AIDS (2007): 7,800*
 

Ongoing biomedical HIV prevention research trials in Rwanda
Vaccines Microbicides

Vaccines

Trial: IAVI B003/IPCAVD-004
Phase: I
Start Date: October 2010
Sponsor, funder, developer: IAVI, HVTN,NIAID, Beth Israel Deaconess Medical Center, Ragon Institute of MGH, MIT, Harvard
Total participants: 212
Vaccine(s): Prime: Ad26.EnvA01 Boost: Ad35- ENV

Back to Top ↑

Microbicides


Trial: Safety and acceptability of dapivirine gel, conducted using daily monitored adherence in healthy HIV-negative women [IPM 014A]
Phase: I/II
Product Being Tested: Dapivirine gel
Sponsor, funder, developer, collaborator: International Partnership for Microbicides, Project Ubuzima
Total participants: 320
Countries: Kenya, Malawi, Rwanda, South Africa, Tanzania
Trial sites in Rwanda: Kigali
Results expected: n/a
More information is available here.
Back to Top ↑
*WHO, UNAIDS, and UNICEF. Epidemiological Fact Sheet on HIV and AIDS: Core data on epidemiological and response Rwanda 2008 Update. 2008. http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_RW.pdf